Clinical trials: Biomarker Change Linked to Breast Cancer
Biomarker Change Linked to Breast Cancer
Changes in Biomarkers Using Prostaglandin Inhibitors
This is a biomarker study with the goal of measuring changes in proteins and gene methylation. This study is not intended for use in diagnosing, mitigating, treating, curing, or preventing disease.
- Trial name
- NCT01769625
- Where
- United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Hartford Hospital